1.
Understanding immune protection against tuberculosis using RNA expression profiling
by von Both, Ulrich
Vaccine, 2015, Vol.33 (40), p.5289-5293
2.
Medical care for migrant children in Europe: a practical recommendation for first and follow-up appointments
by Schrier, Lenneke
European journal of pediatrics, 2019-06-26, Vol.178 (9), p.1449-1467
3.
Pott's disease: a major issue for an unaccompanied refugee minor
by Papan, Cihan
Thorax, 2017-03, Vol.72 (3), p.282-283
4.
Patterns of antimicrobial consumption in neonatal and pediatric intensive care units in Germany and Brazil
by Araujo da Silva, André Ricardo
European journal of clinical microbiology & infectious diseases, 2019-10-31, Vol.39 (2), p.249-255
5.
A boy with a mediastinal mass
by Both, Ulrichvon
The Lancet (British edition), 2004, Vol.364 (9432), p.474-474
6.
Physical and genetic map of the Listeria monocytogenes EGD serotype 1/2a chromosome
by von Both, Ulrich
FEMS microbiology letters, 1999-06-01, Vol.175 (2), p.281-289
7.
Physical and genetic map of the Listeria monocytogenes EGD serotype 1/2a chromosome
by von Both, Ulrich
FEMS microbiology letters, 1999, Vol.175 (2), p.281-289
8.
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
by Gabay, Cem, MD
The Lancet (British edition), 2013, Vol.381 (9877), p.1541-1550
9.
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3...
by Rummel, Mathias J, Prof Dr
The Lancet (British edition), 2013, Vol.381 (9873), p.1203-1210
10.
Evolution of cost structures in rheumatoid arthritis over the past decade
by Huscher, Dörte
Annals of the rheumatic diseases, 2015-04, Vol.74 (4), p.738-745
11.
In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria
by Geva-Zatorsky, Naama
Nature medicine, 2015-09, Vol.21 (9), p.1091-1100
12.
Hematopoietic stem and progenitor cell trafficking
by Mazo, Irina B
Trends in immunology, 2011, Vol.32 (10), p.493-503
13.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority...
by Rummel, Mathias, Prof
The lancet oncology, 2016, Vol.17 (1), p.57-66
14.
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
by Hoch, Eva
European archives of psychiatry and clinical neuroscience, 2019-01-31, Vol.269 (1), p.87-105
15.
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
by MEMPEL, Thorsten R
Nature (London), 2004, Vol.427 (6970), p.154-159
16.
17.
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells
by Rot, Antal
Annual review of immunology, 2004, Vol.22 (1), p.891-928
18.
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an...
by Platzbecker, Uwe
The lancet oncology, 2018-12, Vol.19 (12), p.1668-1679
19.
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
by Van Etten, Richard A
Nature medicine, 2006-10, Vol.12 (10), p.1175-1180
20.
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss
by Weske, Sarah
Nature medicine, 2018-05, Vol.24 (5), p.667-678
